首页 > 最新文献

Multidisciplinary Respiratory Medicine最新文献

英文 中文
Microbiological indoor air quality and associated factors in private clinics of Harar Town, Eastern Ethiopia. 埃塞俄比亚东部哈拉尔镇私人诊所室内空气微生物质量及其相关因素。
IF 2 Q3 RESPIRATORY SYSTEM Pub Date : 2024-12-02 DOI: 10.5826/mrm.2024.969
Liku Muche Temesgen, Tamagnu Sintie Alamirew, Salie Mulat Endalew, Bealemlay Abebe Melake, Wegene Deriba Regassa, Sina Temesgen Tolera, Molla Getie Mehari

Background: Indoor air pollution, including airborne microorganisms, can cause allergies, respiratory diseases, and immune-toxic diseases. Sneezing generates millions of airborne microbial infections, and ventilation sources alter microbial communities. Few studies exist in developing countries, including Ethiopia, and Harar Town. The aim is to assess microbial indoor air quality and associated factors among private clinics, Harar town, Eastern Ethiopia.

Methodology: A cross-sectional study was conducted on 260 private clinic rooms in Harar town, using a systematic random sampling method and passive air sampling. Data was collected using the settle plate method and an observation checklist. Bivariate and multivariate analysis was performed using binary logistic regression, with a P-value of <0.05 considered statistically significant.

Result: The minimum and maximum bacterial loads were 3933 CFU/m3 and 92 CFU/m3 respectively. Based on the pollution degree of the European Commission, the Mean bacterial load (904 CFU/m3) was at higher bacterial load. The highest, lowest, and mean fungal loads were 1967 CFU/m3, 9 CFU/m3 and 401 CFU/m3 respectively. Temperature of <25 °C (AOR = 1.58, p = 0.04, and 95% CI = 1.05, 1.91), >28 °C (AOR = 1.23, P = 0.03, and 95% CI = 1.51, 2.02) were significantly associated with bacterial indoor air quality. Relative humidity of treatment rooms (AOR = 1.87, p = 0.02, and 95% CI = 1.21, 3.09) had an association with bacterial loads. The clinic treatment rooms with a recorded temperature <25 °C (AOR = 6.32, p = 0.01, and 95% CI = 6.10, 8.25) had associated with fungal loads. But the rooms having a temperature of >28 °C (AOR = 0.41, p = 0.04, and 95% CI = 0.31, 0.78) were 59% less likely to comply with the fungal standards compared to rooms having a temperature of 25-28 °C. The clinic rooms with a relative humidity of <30% (AOR = 7.75, p = 0.02, 95% CI = 7.21, 8.39) were 7.75 times more likely to comply with those with a relative humidity of > 60% in the treatment rooms.

Conclusion: Private clinics in Harar had a moderate fungal load and a higher indoor air bacterial concentration when compared to different indoor air standards. Temperature, humidity, inadequate ventilation and the presence of unsanitary attached toilets are some variables associated with microbial loads.

背景:室内空气污染,包括空气中的微生物,可引起过敏、呼吸系统疾病和免疫毒性疾病。打喷嚏会导致数以百万计的空气微生物感染,而通风源会改变微生物群落。在发展中国家,包括埃塞俄比亚和哈拉尔镇,几乎没有研究。目的是评估埃塞俄比亚东部哈拉尔镇私人诊所的微生物室内空气质量及其相关因素。方法:采用系统随机抽样和被动空气抽样的方法,对Harar镇260间私人诊所进行横断面研究。采用沉降板法和观察表收集数据。采用二元logistic回归进行双因素和多因素分析,p值为:结果:最小细菌负荷为3933 CFU/m3,最大细菌负荷为92 CFU/m3。根据欧盟委员会的污染程度,平均细菌负荷为904 CFU/m3,细菌负荷较高。真菌负荷最高、最低和平均分别为1967 CFU/m3、9 CFU/m3和401 CFU/m3。温度28°C (AOR = 1.23, P = 0.03, 95% CI = 1.51, 2.02)与细菌室内空气质量显著相关。治疗室相对湿度与细菌负荷相关(AOR = 1.87, p = 0.02, 95% CI = 1.21, 3.09)。记录温度为28°C的临床治疗室(AOR = 0.41, p = 0.04, 95% CI = 0.31, 0.78)与温度为25-28°C的治疗室相比,符合真菌标准的可能性低59%。医疗室的相对湿度为60%。结论:与不同室内空气标准相比,哈拉尔私人诊所的真菌负荷适中,室内空气细菌浓度较高。温度、湿度、通风不足和不卫生的附属厕所是与微生物负荷相关的一些变量。
{"title":"Microbiological indoor air quality and associated factors in private clinics of Harar Town, Eastern Ethiopia.","authors":"Liku Muche Temesgen, Tamagnu Sintie Alamirew, Salie Mulat Endalew, Bealemlay Abebe Melake, Wegene Deriba Regassa, Sina Temesgen Tolera, Molla Getie Mehari","doi":"10.5826/mrm.2024.969","DOIUrl":"10.5826/mrm.2024.969","url":null,"abstract":"<p><strong>Background: </strong>Indoor air pollution, including airborne microorganisms, can cause allergies, respiratory diseases, and immune-toxic diseases. Sneezing generates millions of airborne microbial infections, and ventilation sources alter microbial communities. Few studies exist in developing countries, including Ethiopia, and Harar Town. The aim is to assess microbial indoor air quality and associated factors among private clinics, Harar town, Eastern Ethiopia.</p><p><strong>Methodology: </strong>A cross-sectional study was conducted on 260 private clinic rooms in Harar town, using a systematic random sampling method and passive air sampling. Data was collected using the settle plate method and an observation checklist. Bivariate and multivariate analysis was performed using binary logistic regression, with a P-value of <0.05 considered statistically significant.</p><p><strong>Result: </strong>The minimum and maximum bacterial loads were 3933 CFU/m3 and 92 CFU/m3 respectively. Based on the pollution degree of the European Commission, the Mean bacterial load (904 CFU/m3) was at higher bacterial load. The highest, lowest, and mean fungal loads were 1967 CFU/m3, 9 CFU/m3 and 401 CFU/m3 respectively. Temperature of <25 °C (AOR = 1.58, p = 0.04, and 95% CI = 1.05, 1.91), >28 °C (AOR = 1.23, P = 0.03, and 95% CI = 1.51, 2.02) were significantly associated with bacterial indoor air quality. Relative humidity of treatment rooms (AOR = 1.87, p = 0.02, and 95% CI = 1.21, 3.09) had an association with bacterial loads. The clinic treatment rooms with a recorded temperature <25 °C (AOR = 6.32, p = 0.01, and 95% CI = 6.10, 8.25) had associated with fungal loads. But the rooms having a temperature of >28 °C (AOR = 0.41, p = 0.04, and 95% CI = 0.31, 0.78) were 59% less likely to comply with the fungal standards compared to rooms having a temperature of 25-28 °C. The clinic rooms with a relative humidity of <30% (AOR = 7.75, p = 0.02, 95% CI = 7.21, 8.39) were 7.75 times more likely to comply with those with a relative humidity of > 60% in the treatment rooms.</p><p><strong>Conclusion: </strong>Private clinics in Harar had a moderate fungal load and a higher indoor air bacterial concentration when compared to different indoor air standards. Temperature, humidity, inadequate ventilation and the presence of unsanitary attached toilets are some variables associated with microbial loads.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"19 ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11661398/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating the complexity of BRAF mutations in non-small cell lung cancer: current insights and future prospects. 驾驭非小细胞肺癌中 BRAF 突变的复杂性:当前见解与未来展望。
IF 2 Q3 RESPIRATORY SYSTEM Pub Date : 2024-11-15 DOI: 10.5826/mrm.2024.992
Sufyan Ibrahim, Smita Shenoy, Ramya Kateel, Shreya Hegde, Amrita Parida, Lipsita Samantaray

There are many challenges that are faced in the treatment of Non-Small Cell Lung Cancer (NSCLC) due to the complexities associated with the tumor. Association of different types of mutations are one of the major complexities. Among these mutations, BRAF mutations are significantly gathering more attention due to their impact on disease progression and therapeutic response. This review provides an analysis of the current understanding of BRAF mutations in NSCLC, focusing on the molecular intricacies, clinical implications, and therapeutic advancements. The article explores the diverse spectrum of BRAF mutations, highlighting the prevalence of specific mutations such as V600E and non-V600E alterations. The review also highlights the intricate signalling pathways influenced by BRAF mutations, shedding light on their role in tumorigenesis and metastasis. Therapeutically, we critically evaluate the existing targeted therapies tailored for BRAF-mutant NSCLC, addressing their efficacy, limitations, and emerging resistance mechanisms. Furthermore, we outline ongoing clinical trials and promising investigational agents that hold potential for reshaping the treatment of NSCLC. This review provides comprehensive current information about the role of BRAF mutations in NSCLC. Understanding the molecular diversity, clinical implications, and therapeutic strategies associated with BRAF-mutant NSCLC is crucial for optimizing patient outcomes and steering the direction of future research in this evolving field.

由于肿瘤的复杂性,非小细胞肺癌(NSCLC)的治疗面临着许多挑战。不同类型突变的关联是主要的复杂性之一。在这些突变中,BRAF 突变因其对疾病进展和治疗反应的影响而备受关注。这篇综述分析了目前对 NSCLC 中 BRAF 基因突变的认识,重点关注其分子复杂性、临床影响和治疗进展。文章探讨了 BRAF 基因突变的多样性,强调了特定基因突变(如 V600E 和非 V600E 基因改变)的普遍性。综述还强调了受 BRAF 突变影响的复杂信号通路,揭示了它们在肿瘤发生和转移中的作用。在治疗方面,我们严格评估了针对 BRAF 突变 NSCLC 的现有靶向疗法,探讨了其疗效、局限性和新出现的耐药机制。此外,我们还概述了正在进行的临床试验和有望重塑 NSCLC 治疗的研究药物。本综述全面介绍了 BRAF 突变在 NSCLC 中的作用。了解与 BRAF 突变 NSCLC 相关的分子多样性、临床影响和治疗策略对于优化患者预后和引导这一不断发展领域的未来研究方向至关重要。
{"title":"Navigating the complexity of BRAF mutations in non-small cell lung cancer: current insights and future prospects.","authors":"Sufyan Ibrahim, Smita Shenoy, Ramya Kateel, Shreya Hegde, Amrita Parida, Lipsita Samantaray","doi":"10.5826/mrm.2024.992","DOIUrl":"10.5826/mrm.2024.992","url":null,"abstract":"<p><p>There are many challenges that are faced in the treatment of Non-Small Cell Lung Cancer (NSCLC) due to the complexities associated with the tumor. Association of different types of mutations are one of the major complexities. Among these mutations, BRAF mutations are significantly gathering more attention due to their impact on disease progression and therapeutic response. This review provides an analysis of the current understanding of BRAF mutations in NSCLC, focusing on the molecular intricacies, clinical implications, and therapeutic advancements. The article explores the diverse spectrum of BRAF mutations, highlighting the prevalence of specific mutations such as V600E and non-V600E alterations. The review also highlights the intricate signalling pathways influenced by BRAF mutations, shedding light on their role in tumorigenesis and metastasis. Therapeutically, we critically evaluate the existing targeted therapies tailored for BRAF-mutant NSCLC, addressing their efficacy, limitations, and emerging resistance mechanisms. Furthermore, we outline ongoing clinical trials and promising investigational agents that hold potential for reshaping the treatment of NSCLC. This review provides comprehensive current information about the role of BRAF mutations in NSCLC. Understanding the molecular diversity, clinical implications, and therapeutic strategies associated with BRAF-mutant NSCLC is crucial for optimizing patient outcomes and steering the direction of future research in this evolving field.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"19 ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11614001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142640289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sense of loneliness and meaning in life in chronic obstructive pulmonary disease patients. Preliminary studies. 慢性阻塞性肺病患者的孤独感和生活意义。初步研究。
IF 2 Q3 RESPIRATORY SYSTEM Pub Date : 2024-11-12 DOI: 10.5826/mrm.2024.994
Kasper Sipowicz, Tadeusz Pietras, Michał Sobstyl, Anna Mosiołek, Monika Różycka-Kosmalska, Jadwiga Mosiołek, Ewa Stefanik-Markowska, Michał Ring, Krystian Kamecki, Marcin Kosmalski

Background: Chronic obstructive pulmonary disease (COPD) interferes with everyday functioning but its impact on the loneliness and the meaning in life of the patients is unclear.

Objectives: to determine whether the COPD severity levels correlate with the sense of loneliness and dimensions of the sense of meaning in life.

Methods: 144 patients with COPD during a period of absence of an infectious exacerbation were examined. The number of infectious exacerbations over the past year, the Modified Medical Research Council (mMRC) dyspnea score, the COPD Assessment Test (CAT) score were determined as well as the feelings of loneliness using the De Jong Gierveld Loneliness Scale (DJGLS) and the sense of meaning in life using the Life Attitude Profile-Revised (LAP-R) questionnaire.

Results: The age, the mMRC and CAT scores, the number of pack/years, as well as the number of infectious exacerbations during the year correlated positively with the feeling of loneliness. These variables (except for age) correlated negatively with the LAP-R scales apart from Existential Vacuum, which correlated positively. The subjects from the COPD severity group D (the most seriously ill people) had the highest level of loneliness, while it was the lowest in the subjects from group A (the least ill people). No statistical difference was observed between groups B and C.

Conclusions: With the increase in the values of the selected parameters determining the severity of COPD the sense of meaning in life decreases and loneliness intensifies.

背景:慢性阻塞性肺病(COPD目的:确定慢性阻塞性肺疾病(COPD)的严重程度是否与患者的孤独感和生活意义感相关。方法:对 144 名慢性阻塞性肺疾病患者在无感染性加重期间的情况进行了调查。方法:研究了 144 名慢性阻塞性肺病患者在未发生感染性病情加重期间的病情严重程度,测定了患者过去一年的感染性病情加重次数、改良医学研究委员会(mMRC)呼吸困难评分、慢性阻塞性肺病评估测试(CAT)评分,并使用德容-吉尔韦尔德孤独感量表(DJGLS)测定了患者的孤独感,使用生活态度档案-修订版(LAP-R)问卷测定了患者的生活意义感:年龄、mMRC和CAT评分、包数/年以及一年中感染性疾病加重的次数与孤独感呈正相关。这些变量(除年龄外)与 LAP-R 量表呈负相关,但与 Existential Vacuum 呈正相关。慢性阻塞性肺病严重程度 D 组受试者(病情最严重者)的孤独感最高,而 A 组受试者(病情最轻者)的孤独感最低。B 组和 C 组之间没有统计学差异:结论:随着决定慢性阻塞性肺病严重程度的选定参数值的增加,生命意义感会降低,孤独感会增强。
{"title":"Sense of loneliness and meaning in life in chronic obstructive pulmonary disease patients. Preliminary studies.","authors":"Kasper Sipowicz, Tadeusz Pietras, Michał Sobstyl, Anna Mosiołek, Monika Różycka-Kosmalska, Jadwiga Mosiołek, Ewa Stefanik-Markowska, Michał Ring, Krystian Kamecki, Marcin Kosmalski","doi":"10.5826/mrm.2024.994","DOIUrl":"10.5826/mrm.2024.994","url":null,"abstract":"<p><strong>Background: </strong>Chronic obstructive pulmonary disease (COPD) interferes with everyday functioning but its impact on the loneliness and the meaning in life of the patients is unclear.</p><p><strong>Objectives: </strong>to determine whether the COPD severity levels correlate with the sense of loneliness and dimensions of the sense of meaning in life.</p><p><strong>Methods: </strong>144 patients with COPD during a period of absence of an infectious exacerbation were examined. The number of infectious exacerbations over the past year, the Modified Medical Research Council (mMRC) dyspnea score, the COPD Assessment Test (CAT) score were determined as well as the feelings of loneliness using the De Jong Gierveld Loneliness Scale (DJGLS) and the sense of meaning in life using the Life Attitude Profile-Revised (LAP-R) questionnaire.</p><p><strong>Results: </strong>The age, the mMRC and CAT scores, the number of pack/years, as well as the number of infectious exacerbations during the year correlated positively with the feeling of loneliness. These variables (except for age) correlated negatively with the LAP-R scales apart from Existential Vacuum, which correlated positively. The subjects from the COPD severity group D (the most seriously ill people) had the highest level of loneliness, while it was the lowest in the subjects from group A (the least ill people). No statistical difference was observed between groups B and C.</p><p><strong>Conclusions: </strong>With the increase in the values of the selected parameters determining the severity of COPD the sense of meaning in life decreases and loneliness intensifies.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"19 ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11614002/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indoor air bacterial quality and associated factors in prison inmate cells of East Hararghe Zone and Harari Regional State, Eastern Ethiopia. 埃塞俄比亚东部东哈拉尔盖区和哈拉里地区州监狱囚犯牢房的室内空气细菌质量及相关因素。
IF 2 Q3 RESPIRATORY SYSTEM Pub Date : 2024-11-04 DOI: 10.5826/mrm.2024.965
Tamagnu Sintie Alamirew, Negga Baraki, Abraham Geremew Gawo, Bealemlay Abebe Melake, Salie Mulat Endalew, Dechasa Adare Mengistu, Fekade Alemu Alemu, Sina Temesgen Tolera, Liku Muche Temesgen, Kefelegn Bayu

Background: Bacterial indoor air load refers to the level of bacteria within and around dwellings and other structures. Pathogens, bacterial cell fragments, and bacterial organisms' byproducts can all pose major issues indoors, especially in prison inmate cells. However, there is lack of data on bacterial load and contributing factors in the East Hararghe zone and Harari regional state. The lack of studies on microbiological indoor air quality in prisons with contributing factors will therefore be filled by this investigation.

Objectives: The study aimed to assess bacterial indoor air load and contributing factors in prison inmate cells from October 1 to October 30, 2020.

Methodology: An institutional cross-sectional study was employed. All of the prisons in the East Hararghe zone and the Harari regional state served as the study's and source population. 62 prison cells were used in the investigation. Samples were obtained using the passively settling plate technique. The data were evaluated through the use of SPSS statistical software, Excel, and the statistical procedures of ANOVA, correlation, and chi-square test.

Results: The maximum and minimum bacterial loads, were recorded at 8:00 am (3027 CFU/m3) and 2:00 pm (1048 (CFU/m3) respectively. The correlation between the temperature and bacterial load was strongly positive (r = 0.680, p = 0.047), and the correlation of the moisture content and bacterial load was strongly negative  (r = -0.671, p = 0.039).

Conclusion: The levels of bacteria were higher than the guideline (2000 CFU/m3). While the relative humidity of indoor air was negatively correlated with bacterial load, temperature and bacterial load were significantly positively correlated. Harari regional state and East Hararghe zone prison commissions should be alarmed to alleviate these problems. The building standards need to be completely updated to the latest standards.

背景:室内空气中的细菌量指的是住宅和其他建筑内部和周围的细菌含量。病原体、细菌细胞碎片和细菌有机体的副产品都会在室内造成严重问题,尤其是在监狱的囚犯牢房中。然而,东哈拉盖地区和哈拉里州缺乏有关细菌负荷和致病因素的数据。因此,本次调查将填补对监狱室内空气质量中微生物及诱发因素研究的空白:本研究旨在评估 2020 年 10 月 1 日至 10 月 30 日期间监狱囚犯牢房的室内空气细菌负荷和诱因:方法:采用机构横断面研究。东哈拉盖区和哈拉里地区州的所有监狱都是研究对象和来源人群。调查中使用了 62 间牢房。采用被动沉降板技术采集样本。使用 SPSS 统计软件、Excel 和方差分析、相关性和卡方检验等统计程序对数据进行了评估:最高和最低细菌量分别出现在上午 8:00 时(3027 CFU/m3)和下午 2:00 时(1048 CFU/m3)。温度与细菌量之间呈强正相关(r = 0.680,p = 0.047),水分含量与细菌量之间呈强负相关(r = -0.671,p = 0.039):结论:细菌含量高于指导标准(2000 CFU/m3)。室内空气相对湿度与细菌量呈负相关,而温度与细菌量呈显著正相关。哈拉里地区州和东哈拉盖区监狱委员会应引起警觉,以缓解这些问题。建筑标准需要完全更新为最新标准。
{"title":"Indoor air bacterial quality and associated factors in prison inmate cells of East Hararghe Zone and Harari Regional State, Eastern Ethiopia.","authors":"Tamagnu Sintie Alamirew, Negga Baraki, Abraham Geremew Gawo, Bealemlay Abebe Melake, Salie Mulat Endalew, Dechasa Adare Mengistu, Fekade Alemu Alemu, Sina Temesgen Tolera, Liku Muche Temesgen, Kefelegn Bayu","doi":"10.5826/mrm.2024.965","DOIUrl":"10.5826/mrm.2024.965","url":null,"abstract":"<p><strong>Background: </strong>Bacterial indoor air load refers to the level of bacteria within and around dwellings and other structures. Pathogens, bacterial cell fragments, and bacterial organisms' byproducts can all pose major issues indoors, especially in prison inmate cells. However, there is lack of data on bacterial load and contributing factors in the East Hararghe zone and Harari regional state. The lack of studies on microbiological indoor air quality in prisons with contributing factors will therefore be filled by this investigation.</p><p><strong>Objectives: </strong>The study aimed to assess bacterial indoor air load and contributing factors in prison inmate cells from October 1 to October 30, 2020.</p><p><strong>Methodology: </strong>An institutional cross-sectional study was employed. All of the prisons in the East Hararghe zone and the Harari regional state served as the study's and source population. 62 prison cells were used in the investigation. Samples were obtained using the passively settling plate technique. The data were evaluated through the use of SPSS statistical software, Excel, and the statistical procedures of ANOVA, correlation, and chi-square test.</p><p><strong>Results: </strong>The maximum and minimum bacterial loads, were recorded at 8:00 am (3027 CFU/m3) and 2:00 pm (1048 (CFU/m3) respectively. The correlation between the temperature and bacterial load was strongly positive (r = 0.680, p = 0.047), and the correlation of the moisture content and bacterial load was strongly negative  (r = -0.671, p = 0.039).</p><p><strong>Conclusion: </strong>The levels of bacteria were higher than the guideline (2000 CFU/m3). While the relative humidity of indoor air was negatively correlated with bacterial load, temperature and bacterial load were significantly positively correlated. Harari regional state and East Hararghe zone prison commissions should be alarmed to alleviate these problems. The building standards need to be completely updated to the latest standards.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"19 ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11613999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gorham-Stout disease and multiple cervical lymphangiomas: case report. 戈勒姆-斯托特病和多发性宫颈淋巴管瘤:病例报告。
IF 2 Q3 RESPIRATORY SYSTEM Pub Date : 2024-10-16 DOI: 10.5826/mrm.2024.957
Maria Alejandra Amezquita, Luz Fernanda Sua, Carlos Alejandro Garcia, Liliana Fernández-Trujillo

Introduction: Gorham-Stout disease is a rare condition characterized by extensive bone loss due to the proliferation of new vascular and lymphatic structures. It can occur in any bone and cause pathologic fractures with poor bone healing. Complications such as effusions and lymphangiomas can also develop. Gorham-Stout disease pathogenesis is still being studied, and treatment options are limited, but sirolimus has shown promise in stabilizing or reducing symptoms.

Case presentation: We present a case of a 19-year-old male with Gorham-Stout disease, multiple cervical lymphangiomas, and several thoracic complications successfully treated with sirolimus.

Conclusions: Rare lymphatic diseases should be considered as a potential cause in adult patients with bone involvement and multiple cystic lesions in the neck, axillary, or abdominal regions after excluding more common causes. The complexity of diagnosing Gorham-Stout disease should be emphasized.

简介戈勒姆-斯托特病(Gorham-Stout disease)是一种罕见的疾病,其特点是由于新血管和淋巴结构的增生而导致大面积骨质流失。它可发生于任何骨骼,并导致病理性骨折和骨愈合不良。此外,还可能出现渗出和淋巴管瘤等并发症。戈勒姆-斯托特病的发病机制仍在研究中,治疗方案也很有限,但西罗莫司在稳定或减轻症状方面已显示出希望:病例介绍:我们介绍了一例患有戈勒姆-斯托特病、多发性颈部淋巴管瘤和多种胸部并发症的 19 岁男性病例,该病例使用西罗莫司成功治疗:结论:对于骨骼受累以及颈部、腋窝或腹部多发性囊性病变的成年患者,在排除更常见的病因后,应将罕见的淋巴疾病视为潜在病因。应强调诊断戈勒姆-斯托特病的复杂性。
{"title":"Gorham-Stout disease and multiple cervical lymphangiomas: case report.","authors":"Maria Alejandra Amezquita, Luz Fernanda Sua, Carlos Alejandro Garcia, Liliana Fernández-Trujillo","doi":"10.5826/mrm.2024.957","DOIUrl":"10.5826/mrm.2024.957","url":null,"abstract":"<p><strong>Introduction: </strong>Gorham-Stout disease is a rare condition characterized by extensive bone loss due to the proliferation of new vascular and lymphatic structures. It can occur in any bone and cause pathologic fractures with poor bone healing. Complications such as effusions and lymphangiomas can also develop. Gorham-Stout disease pathogenesis is still being studied, and treatment options are limited, but sirolimus has shown promise in stabilizing or reducing symptoms.</p><p><strong>Case presentation: </strong>We present a case of a 19-year-old male with Gorham-Stout disease, multiple cervical lymphangiomas, and several thoracic complications successfully treated with sirolimus.</p><p><strong>Conclusions: </strong>Rare lymphatic diseases should be considered as a potential cause in adult patients with bone involvement and multiple cystic lesions in the neck, axillary, or abdominal regions after excluding more common causes. The complexity of diagnosing Gorham-Stout disease should be emphasized.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"19 ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11539906/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The association between smoking/vaping habits and self-reported respiratory symptoms. 吸烟/吸食电子烟习惯与自我报告的呼吸道症状之间的关系。
IF 2 Q3 RESPIRATORY SYSTEM Pub Date : 2024-10-14 DOI: 10.5826/mrm.2024.976
Mohammad Z Darabseh, Aseel Aburub, Christopher I Morse, Hans Degens

Background: Smoking is well known for its harmful effect on the respiratory system, but whether vaping is less harmful is unknown. Therefore, the aim of this study was to assess the association of smoking/vaping habits with self-reported respiratory symptoms in vapers and cigarette smokers.

Methods: An online survey was developed and shared on different vaping and smoking social media platforms and communities.

Results: Out of the 891 respondents, 788 were vapers (77 pure vapers and 711 ex-smokers) and 103 were cigarette smokers. Smokers reported more frequently respiratory symptoms such as chest pain, wheezing and whistling, sputum production, cough, dry mouth, and smokers suffered from more shortness of breath, sore throat and disturbed sleep compared to vapers. The self-reported respiratory symptoms in vapers were mainly related to the nicotine strength of the product and number of puffs per use. There were no significant differences between pure vapers and vapers who were ex-smokers.

Conclusion: Self-reported severe respiratory symptoms were less frequent in vapers than smokers, irrespective of their smoking history. This suggests that vaping is less harmful than cigarette smoking.

背景:吸烟对呼吸系统的危害众所周知,但吸食电子烟是否危害较小还不得而知。因此,本研究旨在评估吸烟/吸食电子烟习惯与吸食电子烟者和吸烟者自我报告的呼吸系统症状之间的关联:方法:制定了一项在线调查,并在不同的吸食和吸烟社交媒体平台和社区上分享:在 891 名受访者中,788 人为吸食者(77 人为纯吸食者,711 人为戒烟者),103 人为吸烟者。与吸食者相比,吸烟者更经常报告呼吸道症状,如胸痛、喘息和啸叫、痰多、咳嗽、口干,吸烟者更容易气短、喉咙痛和睡眠不安。吸食者自我报告的呼吸道症状主要与产品的尼古丁强度和每次吸食的数量有关。纯吸食者和戒烟者之间没有明显差异:结论:与吸烟者相比,无论吸烟史如何,吸食者自我报告的严重呼吸道症状都较少。这表明吸食电子烟比吸烟危害更小。
{"title":"The association between smoking/vaping habits and self-reported respiratory symptoms.","authors":"Mohammad Z Darabseh, Aseel Aburub, Christopher I Morse, Hans Degens","doi":"10.5826/mrm.2024.976","DOIUrl":"https://doi.org/10.5826/mrm.2024.976","url":null,"abstract":"<p><strong>Background: </strong>Smoking is well known for its harmful effect on the respiratory system, but whether vaping is less harmful is unknown. Therefore, the aim of this study was to assess the association of smoking/vaping habits with self-reported respiratory symptoms in vapers and cigarette smokers.</p><p><strong>Methods: </strong>An online survey was developed and shared on different vaping and smoking social media platforms and communities.</p><p><strong>Results: </strong>Out of the 891 respondents, 788 were vapers (77 pure vapers and 711 ex-smokers) and 103 were cigarette smokers. Smokers reported more frequently respiratory symptoms such as chest pain, wheezing and whistling, sputum production, cough, dry mouth, and smokers suffered from more shortness of breath, sore throat and disturbed sleep compared to vapers. The self-reported respiratory symptoms in vapers were mainly related to the nicotine strength of the product and number of puffs per use. There were no significant differences between pure vapers and vapers who were ex-smokers.</p><p><strong>Conclusion: </strong>Self-reported severe respiratory symptoms were less frequent in vapers than smokers, irrespective of their smoking history. This suggests that vaping is less harmful than cigarette smoking.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"19 ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11482041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical utility of bedside Contrast-Enhanced Ultrasound (CEUS) in the diagnosis of pneumonia in elderly patients: Comparison with clinical, -radiological and ultrasound diagnosis. 床旁对比增强超声(CEUS)在老年患者肺炎诊断中的临床实用性:与临床、放射学和超声诊断的比较。
IF 2 Q3 RESPIRATORY SYSTEM Pub Date : 2024-10-01 DOI: 10.5826/mrm.2024.967
Francesco Giangregorio, Emilio Mosconi, Maria Grazia Debellis, Stella Provini, Ciro Esposito, Manuela Mendozza, Rita Raccanelli, Luigi Maresca, Sara Cinquini, Francesco Tursi

Aims: to measure the clinical impact of contrast-enhanced ultrasound (CEUS) in the diagnosis of -community-acquired pneumonia (CAP), compared to clinical, radiological and ultrasound diagnosis.

Methods: 84 patients (47/37 males/females, mean age:78,57±11,7 Y) with clinical suspicion of pneumonia and with ultrasound findings of peripheral lung lesions, were investigated with CEUS for a better characterization. Final diagnosis of 65 cap was obtained with complete disappearance of symptoms and pulmonary nodule(s); 19 neoplasms: 16 patients performed histologically with bronchoscopy; 3 refused (non-invasive diagnosis with basal CT-scan and positron emission tomography (PET) with fluorodeoxyglucose (FDG)). Sensitivity, specificity, overall diagnostic accuracy (ODA) (and corresponding AUROC) of clinical-data (CD), chest X-ray(CXR), Lung-ultrasound(LUS), CEUS were calculated with SPSS 26.0 software.

Results: Final diagnosis: 65 CAP, and 19 chest cancers. 9/65 (13%) patients died, of these 7/9 with older age and heart disease as comorbidity. CD: True-Positive (TP):23, True-negative (TN): 17; False-Positive (FP):2; False-negative (FN):42 (sens:35,4% spec:89,5% ODA10%: PPV:92%, NPV:28,8%) (AUROC±SEauc:0,46±0,076); CXR: TP: 36, TN:14; FP:5, FN:29; (sens: 55,4%; spec: 73,7%; ODA: 32%; PPV:87,5%, NPV:32,66%) (AUROC±SEauc:0,645±0,068). US: TP:59; TN: 14; FP:5, FN:6 (sens: 90,8%, spec: 73,7%, ODA: 84,9%, PPV:92,2%, NPV:70%) (AUROC±SEauc:0,9417±0,024); CEUS: TP: 63; TN: 19; FP:0; FN:2 (sens: 96,9%; spec: 100% ODA: 97,5%; PPV: 100%, NPV:90,5%) (AUROC±SEauc:0,98±0,01).

Conclusions: Clinical-data and chest X-RAYS are insufficient to obtain a correct diagnosis of CAP in elderly population; US demonstrated a good accuracy to establish CAP, but with a relatively low specificity; in these cases, CEUS is able to give a correct characterization, allowing you to save the need for a chest contrast-enhanced-CT (CECT).

目的:与临床、放射学和超声诊断相比,衡量对比增强超声(CEUS)在诊断社区获得性肺炎(CAP)中的临床影响。方法:对 84 例临床怀疑为肺炎并经超声检查发现周围肺部病变的患者(47/37 男/女,平均年龄:78,57±11,7 Y)进行 CEUS 检查,以更好地确定病变特征。最终确诊 65 例患者的症状和肺结节完全消失,其中 19 例为肿瘤:16 名患者通过支气管镜进行了组织学检查;3 名患者拒绝接受检查(通过基础 CT 扫描和含氟脱氧葡萄糖(FDG)的正电子发射断层扫描(PET)进行无创诊断)。用 SPSS 26.0 软件计算了临床数据(CD)、胸部 X 光(CXR)、肺部超声(LUS)和 CEUS 的敏感性、特异性、总体诊断准确性(ODA)(以及相应的 AUROC):最终诊断:65 例 CAP,19 例胸部肿瘤。9/65(13%)名患者死亡,其中 7/9 合并有老年和心脏病。CD:真阳性(TP):23,真阴性(TN):17;假阳性(FP):2;假阴性(FN):42(感度:35,4%,标度:89,5%,ODA10%:PPV:92%,NPV:28,8%) (AUROC±SEauc:0,46±0,076); CXR: TP: 36, TN:14; FP:5, FN:29; (sens: 55,4%; spec: 73,7%; ODA: 32%; PPV:87,5%, NPV:32,66%) (AUROC±SEauc:0,645±0,068).美国TP:59;TN:14;FP:5,FN:6(感觉:90,8%,规格:73,7%,ODA:84,9%,PPV:92,2%,NPV:70%)(AUROC±SEauc:0,9417±0,024);CEUS:TP:63;TN:19;FP:0;FN:2(感觉:96.9%;规格:100% ODA:97.5%;PPV:100%,NPV:90.5%)(AUROC±SEauc:0.98±0.01)。结论临床数据和胸部 X 射线不足以正确诊断老年人群中的 CAP;US 显示了确定 CAP 的良好准确性,但特异性相对较低;在这些病例中,CEUS 能够给出正确的特征,使您无需进行胸部对比增强 CT (CECT)。
{"title":"Clinical utility of bedside Contrast-Enhanced Ultrasound (CEUS) in the diagnosis of pneumonia in elderly patients: Comparison with clinical, -radiological and ultrasound diagnosis.","authors":"Francesco Giangregorio, Emilio Mosconi, Maria Grazia Debellis, Stella Provini, Ciro Esposito, Manuela Mendozza, Rita Raccanelli, Luigi Maresca, Sara Cinquini, Francesco Tursi","doi":"10.5826/mrm.2024.967","DOIUrl":"10.5826/mrm.2024.967","url":null,"abstract":"<p><strong>Aims: </strong>to measure the clinical impact of contrast-enhanced ultrasound (CEUS) in the diagnosis of -community-acquired pneumonia (CAP), compared to clinical, radiological and ultrasound diagnosis.</p><p><strong>Methods: </strong>84 patients (47/37 males/females, mean age:78,57±11,7 Y) with clinical suspicion of pneumonia and with ultrasound findings of peripheral lung lesions, were investigated with CEUS for a better characterization. Final diagnosis of 65 cap was obtained with complete disappearance of symptoms and pulmonary nodule(s); 19 neoplasms: 16 patients performed histologically with bronchoscopy; 3 refused (non-invasive diagnosis with basal CT-scan and positron emission tomography (PET) with fluorodeoxyglucose (FDG)). Sensitivity, specificity, overall diagnostic accuracy (ODA) (and corresponding AUROC) of clinical-data (CD), chest X-ray(CXR), Lung-ultrasound(LUS), CEUS were calculated with SPSS 26.0 software.</p><p><strong>Results: </strong>Final diagnosis: 65 CAP, and 19 chest cancers. 9/65 (13%) patients died, of these 7/9 with older age and heart disease as comorbidity. CD: True-Positive (TP):23, True-negative (TN): 17; False-Positive (FP):2; False-negative (FN):42 (sens:35,4% spec:89,5% ODA10%: PPV:92%, NPV:28,8%) (AUROC±SEauc:0,46±0,076); CXR: TP: 36, TN:14; FP:5, FN:29; (sens: 55,4%; spec: 73,7%; ODA: 32%; PPV:87,5%, NPV:32,66%) (AUROC±SEauc:0,645±0,068). US: TP:59; TN: 14; FP:5, FN:6 (sens: 90,8%, spec: 73,7%, ODA: 84,9%, PPV:92,2%, NPV:70%) (AUROC±SEauc:0,9417±0,024); CEUS: TP: 63; TN: 19; FP:0; FN:2 (sens: 96,9%; spec: 100% ODA: 97,5%; PPV: 100%, NPV:90,5%) (AUROC±SEauc:0,98±0,01).</p><p><strong>Conclusions: </strong>Clinical-data and chest X-RAYS are insufficient to obtain a correct diagnosis of CAP in elderly population; US demonstrated a good accuracy to establish CAP, but with a relatively low specificity; in these cases, CEUS is able to give a correct characterization, allowing you to save the need for a chest contrast-enhanced-CT (CECT).</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"19 ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11482042/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Italian Delphi Consensus on the Triple inhalation Therapy in Chronic Obstructive Pulmonary Disease. 意大利关于慢性阻塞性肺病三重吸入疗法的德尔菲共识。
IF 2 Q3 RESPIRATORY SYSTEM Pub Date : 2024-09-18 DOI: 10.5826/mrm.2024.949
Paolo Solidoro, Federico Dente, Claudio Micheletto, Giovanni Pappagallo, Girolamo Pelaia, Alberto Papi

Background: The management of chronic obstructive pulmonary disease (COPD) lacks standardization due to the diverse clinical presentation, comorbidities, and limited acceptance of recommended approaches by physicians. To address this, a multicenter study was conducted among Italian respiratory physicians to assess consensus on COPD management and pharmacological treatment.

Methods: The study employed the Delphi process using the Estimate-Talk-Estimate method, involving a scientific board and expert panel. During a 6-month period, the scientific board conducted the first Delphi round and identified 11 broad areas of COPD management to be evaluated while the second Delphi round translated all 11 items into statements. The statements were subsequently presented to the expert panel for independent rating on a nine-point scale. Consensus was considered achieved if the median score was 7 or higher. Consistently high levels of consensus were observed in the first rating, allowing the scientific board to finalize the statements without requiring further rounds.

Results: Topics generating substantial discussion included the pre-COPD phase, patient-reported outcomes, direct escalation from a single bronchodilator to triple therapy, and the role of adverse events, particularly pneumonia, in guiding triple therapy prescriptions. Notably, these topics exhibited higher standard deviations, indicating greater variation in expert opinions.

Conclusions: The study emphasized the significance that Italian pulmonologists attribute to managing mortality, tailoring treatments, and addressing cardiovascular comorbidities in COPD patients. While unanimous consensus was not achieved for all statements, the results provide valuable insights to inform clinical decision-making among physicians and contribute to a better understanding of COPD management practices in Italy.

背景:由于慢性阻塞性肺疾病(COPD)的临床表现和并发症多种多样,而且医生对推荐方法的接受程度有限,因此慢性阻塞性肺疾病(COPD)的管理缺乏标准化。为此,我们在意大利呼吸科医生中开展了一项多中心研究,以评估慢性阻塞性肺病管理和药物治疗的共识:方法:研究采用德尔菲程序,使用估计-谈话-估计方法,由科学委员会和专家小组参与。在为期 6 个月的时间里,科学委员会进行了第一轮德尔菲,确定了需评估的 11 个慢性阻塞性肺病管理的广泛领域,而第二轮德尔菲则将所有 11 个项目转化为声明。声明随后提交给专家小组,由专家小组按照九级评分标准进行独立评分。如果中位数分数达到或超过 7 分,则认为达成了共识。在第一轮评分中,各方达成了一致的高度共识,因此科学委员会无需再进行第二轮评分,即可最终确定声明:结果:引起大量讨论的主题包括 COPD 前期、患者报告结果、从单一支气管扩张剂直接升级到三联疗法,以及不良事件(尤其是肺炎)在指导三联疗法处方中的作用。值得注意的是,这些主题的标准偏差较大,表明专家意见的差异更大:这项研究强调了意大利肺科专家对控制死亡率、调整治疗方法和解决慢性阻塞性肺疾病患者心血管合并症问题的重视。虽然未能就所有声明达成一致共识,但研究结果为医生的临床决策提供了宝贵的见解,有助于更好地了解意大利的慢性阻塞性肺病管理实践。
{"title":"An Italian Delphi Consensus on the Triple inhalation Therapy in Chronic Obstructive Pulmonary Disease.","authors":"Paolo Solidoro, Federico Dente, Claudio Micheletto, Giovanni Pappagallo, Girolamo Pelaia, Alberto Papi","doi":"10.5826/mrm.2024.949","DOIUrl":"https://doi.org/10.5826/mrm.2024.949","url":null,"abstract":"<p><strong>Background: </strong>The management of chronic obstructive pulmonary disease (COPD) lacks standardization due to the diverse clinical presentation, comorbidities, and limited acceptance of recommended approaches by physicians. To address this, a multicenter study was conducted among Italian respiratory physicians to assess consensus on COPD management and pharmacological treatment.</p><p><strong>Methods: </strong>The study employed the Delphi process using the Estimate-Talk-Estimate method, involving a scientific board and expert panel. During a 6-month period, the scientific board conducted the first Delphi round and identified 11 broad areas of COPD management to be evaluated while the second Delphi round translated all 11 items into statements. The statements were subsequently presented to the expert panel for independent rating on a nine-point scale. Consensus was considered achieved if the median score was 7 or higher. Consistently high levels of consensus were observed in the first rating, allowing the scientific board to finalize the statements without requiring further rounds.</p><p><strong>Results: </strong>Topics generating substantial discussion included the pre-COPD phase, patient-reported outcomes, direct escalation from a single bronchodilator to triple therapy, and the role of adverse events, particularly pneumonia, in guiding triple therapy prescriptions. Notably, these topics exhibited higher standard deviations, indicating greater variation in expert opinions.</p><p><strong>Conclusions: </strong>The study emphasized the significance that Italian pulmonologists attribute to managing mortality, tailoring treatments, and addressing cardiovascular comorbidities in COPD patients. While unanimous consensus was not achieved for all statements, the results provide valuable insights to inform clinical decision-making among physicians and contribute to a better understanding of COPD management practices in Italy.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"19 ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11414512/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A study on physicians' knowledge and practices of asthma management in Angola. 关于安哥拉医生对哮喘管理的认识和实践的研究。
IF 2 Q3 RESPIRATORY SYSTEM Pub Date : 2024-09-13 DOI: 10.5826/mrm.2024.968
Nsiku Lutete, Margarete Arrais, Jorge M R Gama, Luis Taborda-Barata

Background: Asthma is the most common chronic non-communicable disease in children and one of the most common in adults, and the majority of asthma-related deaths are attributed to middle- and low-income countries. Physicians' knowledge and practice have been recognized as fundamental elements in the approach to the asthmatic patient with an impact on the treatment and control of the disease. This study aimed to assess the knowledge and practice of Angolan physicians in the management of asthma, as well as to identify the main gaps.

Methods: It was a cross-sectional study carried out in Angola. The data were collected through an online questionnaire to assess the knowledge about asthma among the physicians and the Physicians Practice Assessment Questionnaire. Categorical variables were described with frequencies and percentages. All associations between good practice and possible predictors were established with logistic regression analysis. P<0.05 was considered statistically significant.

Results: A total of 204 physicians throughout Angola participated; the majority of whom were female, aged -between 31 and 40, and from the Luanda province. The average percentage of correct answers for all domains was 65.8% (±SD11.1%). The lowest percentages were in the answers about the diagnosis, drugs, and the signs of an asthma attack. Out of the 204 participants, 81.9% of physicians confirmed seeing patients with asthma. The average percentage of them who reported practicing asthma management based on recommended guidelines was 59.8% (±SD27.8%). More than half of the physicians did not achieve that percentage. The lowest percentages of correct answers concerned assessment of the inhaler technique, provision of a written referral for asthma education, and use of the GINA guidelines to assess the patient's asthma control. Concerning the predictors of best practices, our results showed that being a physician of older age and with more work experience, as well as having the category of specialist were significant predictors of adherence to recommended practices for asthma management.

Conclusions: The physicians' level of knowledge about asthma was moderate, but there are important practical gaps in asthma management regarding standard guidelines.

背景:哮喘是儿童最常见的慢性非传染性疾病,也是成人最常见的疾病之一,大多数与哮喘有关的死亡病例发生在中等收入和低收入国家。医生的知识和实践被认为是治疗哮喘患者的基本要素,对疾病的治疗和控制具有重要影响。本研究旨在评估安哥拉医生在哮喘治疗方面的知识和实践,并找出主要差距:这是一项在安哥拉进行的横断面研究。数据通过在线问卷调查和医生实践评估问卷调查收集,以评估医生对哮喘的了解程度。分类变量以频率和百分比进行描述。通过逻辑回归分析确定了良好实践与可能的预测因素之间的所有关联。结果安哥拉全国共有204名医生参加了调查,其中大多数为女性,年龄在31至40岁之间,来自罗安达省。所有领域的平均正确率为65.8%(±SD11.1%)。正确率最低的是关于诊断、药物和哮喘发作征兆的答案。在 204 名参与者中,81.9% 的医生确认曾接诊过哮喘患者。其中根据推荐指南进行哮喘管理的平均比例为 59.8%(±SD27.8%)。超过一半的医生没有达到这一比例。正确答案的最低百分比涉及吸入器技术评估、提供哮喘教育书面转介以及使用 GINA 指南评估患者的哮喘控制情况。关于最佳实践的预测因素,我们的研究结果表明,年龄较大、工作经验较丰富以及拥有专科医生类别的医生是坚持哮喘管理推荐实践的重要预测因素:结论:医生对哮喘的了解程度尚可,但在哮喘管理的标准指南方面还存在很大的实际差距。
{"title":"A study on physicians' knowledge and practices of asthma management in Angola.","authors":"Nsiku Lutete, Margarete Arrais, Jorge M R Gama, Luis Taborda-Barata","doi":"10.5826/mrm.2024.968","DOIUrl":"https://doi.org/10.5826/mrm.2024.968","url":null,"abstract":"<p><strong>Background: </strong>Asthma is the most common chronic non-communicable disease in children and one of the most common in adults, and the majority of asthma-related deaths are attributed to middle- and low-income countries. Physicians' knowledge and practice have been recognized as fundamental elements in the approach to the asthmatic patient with an impact on the treatment and control of the disease. This study aimed to assess the knowledge and practice of Angolan physicians in the management of asthma, as well as to identify the main gaps.</p><p><strong>Methods: </strong>It was a cross-sectional study carried out in Angola. The data were collected through an online questionnaire to assess the knowledge about asthma among the physicians and the Physicians Practice Assessment Questionnaire. Categorical variables were described with frequencies and percentages. All associations between good practice and possible predictors were established with logistic regression analysis. P<0.05 was considered statistically significant.</p><p><strong>Results: </strong>A total of 204 physicians throughout Angola participated; the majority of whom were female, aged -between 31 and 40, and from the Luanda province. The average percentage of correct answers for all domains was 65.8% (±SD11.1%). The lowest percentages were in the answers about the diagnosis, drugs, and the signs of an asthma attack. Out of the 204 participants, 81.9% of physicians confirmed seeing patients with asthma. The average percentage of them who reported practicing asthma management based on recommended guidelines was 59.8% (±SD27.8%). More than half of the physicians did not achieve that percentage. The lowest percentages of correct answers concerned assessment of the inhaler technique, provision of a written referral for asthma education, and use of the GINA guidelines to assess the patient's asthma control. Concerning the predictors of best practices, our results showed that being a physician of older age and with more work experience, as well as having the category of specialist were significant predictors of adherence to recommended practices for asthma management.</p><p><strong>Conclusions: </strong>The physicians' level of knowledge about asthma was moderate, but there are important practical gaps in asthma management regarding standard guidelines.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"19 ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11414511/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of biological therapies on laboratory outcomes and FEV1 in patients with severe eosinophilic asthma with chronic rhinosinusitis: a real-life study from Saudi Arabia. 生物疗法对严重嗜酸性粒细胞性哮喘合并慢性鼻窦炎患者的实验室结果和 FEV1 的影响:一项来自沙特阿拉伯的真实研究。
IF 2 Q3 RESPIRATORY SYSTEM Pub Date : 2024-09-09 DOI: 10.5826/mrm.2024.985
Usama Abu Elhassan, Salihah Y Al-Mani, Saad M A Alqahtani, Medhat Elnamaky, Abdulaziz Alfaifi, Mohammed A Alshehri, Haneen A Alasiri, Ali S Kadasah, Abdullah Musleh, Fawwaz A Alshafa, Muhammad S S Qureshi, Abdulmohsen Y Assiri, Abdulrahman I Falqi, Bader I Asiri, Haider M O Ahmed, Saleem Alshehry, Abdelrahman M Abdalla

                                                                 Abstract Background: Few studies have addressed the effects of biological therapies on laboratory outcomes and changes in FEV1 in patients with severe asthma (SA) and chronic rhinosinusitis (CRS). We aimed to study the effect of three biological therapies on laboratory outcomes and FEV1 in Saudi Arabian patients with SA and CRS.

Methods: From March to September 2022, a retrospective observational cohort study was undertaken at the severe asthma clinics of the Armed Forces Hospital-Southern Region (AFHSR) and King Khalid University Hospital, Abha, Saudi Arabia, to delineate the effects of 3 biological therapies (benralizumab, dupilumab, and omalizumab) in adults with SA and concomitant CRS in terms of FEV1 and laboratory parameters (serum IgE and eosinophilic counts).

Results: Eighty patients were enrolled, with a mean age of 46.68. There were 45 (56%) females and 35 (44%) males. There were significant improvements in FEV1 and laboratory parameters (serum IgE and eosinophilic counts) after 6 &12 months of biological therapies compared to pre-biological therapies (p<0.001, each). The response was different among different biological therapies. The improvements in FEV1, serum IgE, and eosinophilic counts were manifest with benralizumab and dupilumab but not with omalizumab.

Conclusions: Results from the first study from two large Saudi Arabian tertiary centers for patients with severe asthma and chronic rhinosinusitis agree with and support those of worldwide real-life ones. One-year follow-up of patients with SA and CRS showed the effectiveness of benralizumab and dupilumab, but not omalizumab, regarding FEV1, serum IgE, and eosinophilic counts. Further prospective multicenter studies are warranted.

摘要 背景:很少有研究探讨生物疗法对严重哮喘(SA)和慢性鼻炎(CRS)患者的实验室结果和 FEV1 变化的影响。我们旨在研究三种生物疗法对沙特阿拉伯哮喘和慢性鼻炎患者的实验室结果和 FEV1 的影响:2022年3月至9月,沙特阿拉伯阿巴哈市武装部队医院(AFHSR)和哈立德国王大学医院的重症哮喘门诊开展了一项回顾性观察队列研究,以确定三种生物疗法(苯拉利珠单抗、杜匹单抗和奥马珠单抗)对患有哮喘并同时患有CRS的成人患者的FEV1和实验室指标(血清IgE和嗜酸性粒细胞计数)的影响:80名患者接受了治疗,平均年龄为46.68岁。其中女性 45 人(56%),男性 35 人(44%)。与接受生物疗法前相比,接受生物疗法 6 个月和 12 个月后,患者的 FEV1 和实验室指标(血清 IgE 和嗜酸性粒细胞计数)均有明显改善(p 结论:沙特阿拉伯两家大型三级医疗中心对严重哮喘和慢性鼻炎患者进行的首次研究结果与世界范围内的实际研究结果一致,并为其提供了支持。对 SA 和 CRS 患者的一年随访结果显示,苯拉利单抗和杜匹单抗在 FEV1、血清 IgE 和嗜酸性粒细胞计数方面有效,而奥马珠单抗无效。有必要进一步开展前瞻性多中心研究。
{"title":"Impact of biological therapies on laboratory outcomes and FEV1 in patients with severe eosinophilic asthma with chronic rhinosinusitis: a real-life study from Saudi Arabia.","authors":"Usama Abu Elhassan, Salihah Y Al-Mani, Saad M A Alqahtani, Medhat Elnamaky, Abdulaziz Alfaifi, Mohammed A Alshehri, Haneen A Alasiri, Ali S Kadasah, Abdullah Musleh, Fawwaz A Alshafa, Muhammad S S Qureshi, Abdulmohsen Y Assiri, Abdulrahman I Falqi, Bader I Asiri, Haider M O Ahmed, Saleem Alshehry, Abdelrahman M Abdalla","doi":"10.5826/mrm.2024.985","DOIUrl":"10.5826/mrm.2024.985","url":null,"abstract":"<p><p>                                                                 Abstract Background: Few studies have addressed the effects of biological therapies on laboratory outcomes and changes in FEV1 in patients with severe asthma (SA) and chronic rhinosinusitis (CRS). We aimed to study the effect of three biological therapies on laboratory outcomes and FEV1 in Saudi Arabian patients with SA and CRS.</p><p><strong>Methods: </strong>From March to September 2022, a retrospective observational cohort study was undertaken at the severe asthma clinics of the Armed Forces Hospital-Southern Region (AFHSR) and King Khalid University Hospital, Abha, Saudi Arabia, to delineate the effects of 3 biological therapies (benralizumab, dupilumab, and omalizumab) in adults with SA and concomitant CRS in terms of FEV1 and laboratory parameters (serum IgE and eosinophilic counts).</p><p><strong>Results: </strong>Eighty patients were enrolled, with a mean age of 46.68. There were 45 (56%) females and 35 (44%) males. There were significant improvements in FEV1 and laboratory parameters (serum IgE and eosinophilic counts) after 6 &12 months of biological therapies compared to pre-biological therapies (p<0.001, each). The response was different among different biological therapies. The improvements in FEV1, serum IgE, and eosinophilic counts were manifest with benralizumab and dupilumab but not with omalizumab.</p><p><strong>Conclusions: </strong>Results from the first study from two large Saudi Arabian tertiary centers for patients with severe asthma and chronic rhinosinusitis agree with and support those of worldwide real-life ones. One-year follow-up of patients with SA and CRS showed the effectiveness of benralizumab and dupilumab, but not omalizumab, regarding FEV1, serum IgE, and eosinophilic counts. Further prospective multicenter studies are warranted.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"19 ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11414510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Multidisciplinary Respiratory Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1